LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Dec 22, 2017
Clinical News
Eisai reports Phase Ib/II data for Halaven plus Keytruda in TNBC
Read More
BioCentury
|
Aug 15, 2016
Clinical News
Halaven eribulin mesylate regulatory update
Read More
BioCentury
|
May 30, 2016
Clinical News
Halaven eribulin mesylate: Phase III data
Read More
BioCentury
|
May 16, 2016
Clinical News
Halaven eribulin mesylate regulatory update
Read More
BioCentury
|
Apr 25, 2016
Clinical News
Halaven eribulin mesylate regulatory update
Read More
BioCentury
|
Mar 7, 2016
Clinical News
Eribulin mesylate regulatory update
Read More
BioCentury
|
Feb 8, 2016
Clinical News
Halaven eribulin mesylate regulatory update
Read More
BioCentury
|
Oct 5, 2015
Clinical News
Eribulin mesylate regulatory update
Read More
BioCentury
|
Jun 8, 2015
Clinical News
Halaven eribulin mesylate: Additional Phase III data
Read More
BioCentury
|
Mar 2, 2015
Clinical News
Eribulin mesylate: Phase III data
Read More
Items per page:
10
1 - 10 of 59
